Medeon Financial Statements From 2010 to 2024
| 6499 Stock | TWD 42.50 1.15 2.63% |
Check Medeon Biodesign financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medeon Biodesign's main balance sheet or income statement drivers, such as , as well as many indicators such as . Medeon financial statements analysis is a perfect complement when working with Medeon Biodesign Valuation or Volatility modules.
Medeon |
Medeon Biodesign Company Current Valuation Analysis
Medeon Biodesign's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medeon Biodesign Current Valuation | 3.37 B |
Most of Medeon Biodesign's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medeon Biodesign is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medeon Biodesign has a Current Valuation of 3.37 B. This is 76.53% lower than that of the Healthcare sector and 63.13% lower than that of the Medical Instruments & Supplies industry. The current valuation for all Taiwan stocks is 79.72% higher than that of the company.
Medeon Biodesign Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medeon Biodesign's current stock value. Our valuation model uses many indicators to compare Medeon Biodesign value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medeon Biodesign competition to find correlations between indicators driving Medeon Biodesign's intrinsic value. More Info.Medeon Biodesign is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medeon Biodesign's earnings, one of the primary drivers of an investment's value.About Medeon Biodesign Financial Statements
Medeon Biodesign investors use historical fundamental indicators, such as Medeon Biodesign's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medeon Biodesign. Please read more on our technical analysis and fundamental analysis pages.
Pair Trading with Medeon Biodesign
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medeon Biodesign position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medeon Biodesign will appreciate offsetting losses from the drop in the long position's value.Moving against Medeon Stock
The ability to find closely correlated positions to Medeon Biodesign could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medeon Biodesign when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medeon Biodesign - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medeon Biodesign to buy it.
The correlation of Medeon Biodesign is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medeon Biodesign moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medeon Biodesign moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medeon Biodesign can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medeon Stock Analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.